JI
Sen. James Inhofe (R-OK) bought $15K-$50K of CRSP stock
James Inhofe, U.S. Senator (R-OK), disclosed a purchase of CRISPR Therapeutics AG (CRSP) stock worth $15K-$50K in a STOCK Act filing on Nov 8, 2017.
The trade happened on Oct 19, 2017, 20 days before it was made public.
CRSP has moved +124.7% since the trade date, from $18.97 to $42.62 (Nov 12, 2026 close).
- Traded
- Oct 19, 2017
- Disclosed
- Nov 8, 2017
- Filing delay
- 20 days
- Price since
- +124.7%
- Source
- STOCK Act disclosure